Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine
IRELAND – AstraZeneca has announced that its rare disease group Alexion will invest €65 million (US$68.7M) to scale up its biologics manufacturing capacity and expand R&D efforts at its sites…
Read More
USA – MATTER, the premier healthcare incubator and innovation hub, has announced the launch of a new incubation program in collaboration with Amazon Web Services (AWS) called AWS Expand. The…
Read More
AFRICA – The government of Sweden and the Clinton Health Access Initiative (CHAI) have announced a partnership to accelerate progress in Africa toward the goals of sexual and reproductive health…
Read More
SWITZERLAND –Novartis has said it will invest US$250 million to advance research and development of new treatments to combat neglected tropical diseases and malaria, as part of its commitment over…
Read More
BELGIUM – The European Union is set to invest 890 million euros (US$936 million) in vaccine and drug production in Latin America and Caribbean countries, European Commission chief Ursula von…
Read More
RWANDA – The German pharmaceutical company BioNTech has broken ground for the production site of its COVID-19 vaccine in Rwanda’s capital, Kigali. According to BioNTech, the facility, dubbed the African…
Read More
RWANDA – Global leaders led by African Heads of State have announced the first in a series of pledges totaling US$4 billion to accelerate progress against Malaria and Neglected Tropical…
Read More
RWANDA –Commonwealth Heads of Government and leaders from around the world are set to meet in Rwanda to make bold commitments toward ending malaria and neglected tropical diseases (NTDs). The…
Read More
INDIA – Apollo Cancer Centres has collaborated with Datar Cancer Genetics to launch a revolutionary blood test that can detect breast cancers at early stages in asymptomatic individuals with high…
Read More
NETHERLANDS – The European Medicines Agency (EMA) has accepted Sandoz’s application for regulatory review of Hyrimoz, the company’s high concentration biosimilar of AbbVie’s Humira. If approved, Hyrimoz would be used…
Read More